AI May Be Used to Find New Cures in Old Drugs

Each year, trillions of dollars are spent in the pharmaceutical industry to design “new drugs” that might typically take more than 10 years to reach the market.

But now, through technology, big tech giants and driven startups are trying to change that by leveraging existing drug data to cure life-threatening diseases. If successful, this would mean redefining “discovery.”

Repurpose.AI, a San Diego company that uses machine learning to aid drug discovery, has joined the fight to treat the novel coronavirus.


This article originally appeared on the San Diego Business Journal, prior to the rebrand of Repurpose.AI to Model Medicines, read the full article here.

Previous
Previous

COVID-19 Response: Unprecedented Opportunities In Digital Health & Biotech

Next
Next

Model Medicines Announces Appointment of Tushar Menon, Ph.D. to its Advisory Board